THE EFFECTIVENESS OF ALLOFERON IN THE COMPLEX THERAPY OF CHRONIC RECURRENT PAPILLOMAVIRUS CYSTITIS

Author:

Ibishev Khalid Suleymanovich,Krahotkin Denis Valerievich,Mammadov Vahid Kamalovich,Singe Andrey Ivanovich

Abstract

Introduction: Chronic recurrent cystitis (CRC) for women is one of the most pressing and unresolved problems of modern urology. Purpose of the research: To study the effectiveness of Alloferon (Allokin-alpha) in the complex therapy of chronic reactive papillomavirus cystitis. Materials and methods: 46 patients with CRC PV-etiology were examined, which, depending on the therapy, were randomized into two groups. Patients of group I (n=22) received combination therapy supplemented with Alloferon, which was injected subcutaneously every 1 day, for a course of 6 injections. Group II (control) (n=24) - combination therapy without study drug. The effectiveness of treatment was assessed immediately after treatment, after 1, 3, 6 months, from the beginning of therapy. Results: When analyzing the results of treatment, a significant improvement in clinical indicators was noted in patients of group I who received complex therapy, which included Alloferon, after 1 month from the start of treatment, there was a significant decrease in pain symptoms and LUTS, an improvement in the quality of life of patients compared with group II. When evaluating the dynamics of laboratory data, in the general analysis of urine, a significant decrease in the level of leukocytes and erythrocytes in the general analysis of urine was noted. In addition, the analysis of the data of cytological examination of urine revealed a decrease in the specific sign of papillomavirus lesions of the bladder - coylocytosis: after 6 months. From the start of therapy, no coylocytes were detected in group I, while in group II, coylocytes in urine were detected in 8 (33.3%) patients. Conclusions: The use of Alloferon (Allokin-alpha) in the complex therapy of patients with CRC PV etiology improved clinical and laboratory parameters after 1 month. after starting therapy, while the undoubted advantage of the drug is a faster reduction in pain, which significantly increased the quality of life.

Publisher

Crossref

Reference15 articles.

1. Gadzhieva Z.K., Kazilov Yu.B. Features of the prevention of recurrent lower urinary tract infections. Urologiia. 2016;(3):65-76. Russian (Гаджиева З.К., Казилов Ю.Б. Особенности подхода к профилактике рецидивирующей инфекции нижних мочевыводящих путей. Урология. 2016;(3):65-76).

2. Kuz'min I.V., Slesarevskaya M.N., Al'-Shukri S.KH. D-mannose for the prevention and treatment of lower urinary tract infections: pathogenetic basis and clinical results. Urologiia. 2020;(4):131-138. Russian (Кузьмин И.В., Слесаревская М.Н., Аль-Шукри С.Х. D-манноза в профилактике и лечении инфекций нижних мочевыводящих путей: патогенетические основы и клинические результаты. Урология. 2020;(4):131-138).

3. Lee P.J., Kuo H.C. High incidence of lower urinary tract dysfunction in women with recurrent urinary tract infections. Low Urin Tract Symptoms. 2020;12(1):33-40.

4. Ibishev KH.S. A modern perspective on the treatment and prevention of recurrent lower urinary tract infections. Effektivnaya farmakoterapiya. 2015;(26):28-30. Russian (Ибишев Х.С. Современный взгляд на лечение и профилактику рецидивирующей инфекции нижних мочевых путей. Эффективная фармакотерапия. 2015;(26):28-30).

5. Kuz'menko A.V., Kuz'menko V.V, Gyaurgiyev T.A. Current trends in the treatment of chronic recurrent bacterial cystitis. Urologiia. 2020;(6): 52-57. Russian (Кузьменко А.В., Кузьменко В.В, Гяургиев Т.А. Современные тенденции в лечении хронического рецидивирующего бактериального цистита. Урология. 2020;(6):52-57).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3